Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.59
0.04 (0.27%)
At close: Jun 16, 2025, 3:59 PM
15.29
4.83%
After-hours: Jun 16, 2025, 05:54 PM EDT
Denali Therapeutics Revenue
Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
443
Market Cap
2.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|